Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1986 Jul;88(3):569–576. doi: 10.1111/j.1476-5381.1986.tb10237.x

Urinary kallikrein excretion during inhibition of endogenous angiotensin II in the pig.

B R Binder, M Maier, H Rana, M Starlinger, Z Zhegu
PMCID: PMC1916975  PMID: 3638148

Abstract

This study was performed to assess the possible contribution of endogenous angiotensin II (AII) to the regulation of urinary kallikrein excretion. The AII antagonist saralasin or the saline vehicle was infused into the aorta above the renal arteries of pigs under halothane-O2/N2O anaesthesia. Systemic and renal functional parameters were followed for 140 min and during stimulation of the reninangiotensin system by haemorrhage. Urinary kallikrein excretion, determined as kininogenase activity, was increased immediately upon both initiation and termination of the 2 h saralasin infusion into pigs not subjected to haemorrhage. Renal cortical blood flow (RCBF) was maintained, in both saline and saralasin-treated animals at blood pressures as low as 70 mm Hg, while glomerular filtration rate was dissociated during saralasin infusion. As long as RCBF was maintained, urinary kallikrein excretion rate was elevated during the progressive hypotension in both saline and saralasin-treated animals. These findings confirm a close relationship between the maintenance of RCBF and increased activity of the kallikrein-kinin system whether or not AII is antagonized, and indicate that during haemorrhage the kallikrein-kinin system is stimulated by a mechanism not involving AII.

Full text

PDF
569

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arendshorst W. J., Finn W. F. Renal hemodynamics in the rat before and during inhibition of angiotensin II. Am J Physiol. 1977 Oct;233(4):F290–F297. doi: 10.1152/ajprenal.1977.233.4.F290. [DOI] [PubMed] [Google Scholar]
  2. Baylis C., Deen W. M., Myers B. D., Brenner B. M. Effects of some vasodilator drugs on transcapillary fluid exchange in renal cortex. Am J Physiol. 1976 Apr;230(4):1148–1158. doi: 10.1152/ajplegacy.1976.230.4.1148. [DOI] [PubMed] [Google Scholar]
  3. Colina-Chourio J., McGiff J. C., Nasjletti A. Effects of aldosterone and deoxycorticosterone on the urniary excretion of kallikrein and of prostaglandin E-like substance in the rat. Contrib Nephrol. 1978;12:126–131. doi: 10.1159/000401660. [DOI] [PubMed] [Google Scholar]
  4. Devynck M. A., Meyer P. Angiotensin receptors. Biochem Pharmacol. 1978 Jan 1;27(1):1–5. doi: 10.1016/0006-2952(78)90249-6. [DOI] [PubMed] [Google Scholar]
  5. HILTON S. M., LEWIS G. P. The mechanism of the functional hyperaemia in the submandibular salivary gland. J Physiol. 1955 Aug 29;129(2):253–271. doi: 10.1113/jphysiol.1955.sp005351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hall J. E., Coleman T. G., Guyton A. C., Kastner P. R., Granger J. P. Control of glomerular filtration rate by circulating angiotensin II. Am J Physiol. 1981 Sep;241(3):R190–R197. doi: 10.1152/ajpregu.1981.241.3.R190. [DOI] [PubMed] [Google Scholar]
  7. Hall J. E., Guyton A. C., Jackson T. E., Coleman T. G., Lohmeier T. E., Trippodo N. C. Control of glomerular filtration rate by renin-angiotensin system. Am J Physiol. 1977 Nov;233(5):F366–F372. doi: 10.1152/ajprenal.1977.233.5.F366. [DOI] [PubMed] [Google Scholar]
  8. Hall J. E., Guyton A. C., Trippodo N. C., Lohmeier T. E., McCaa R. E., Cowley A. W., Jr Intrarenal control of electrolyte excretion by angiotensin II. Am J Physiol. 1977 Jun;232(6):F538–F544. doi: 10.1152/ajprenal.1977.232.6.F538. [DOI] [PubMed] [Google Scholar]
  9. Jakschik B. A., Marshall G. R., Kourik J. L., Needleman P. Profile of circulating vasoactive substances in hemorrhagic shock and their pharmacologic manipulation. J Clin Invest. 1974 Oct;54(4):842–852. doi: 10.1172/JCI107824. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Johnston C. I., Clappison B., McGrath B. P., Matthews P. G., Millar J. A., Anderson W. P. Kallikrein, kinins and blood pressure - effects of angiotensin-converting enzyme inhibition. Prog Biochem Pharmacol. 1980;17:123–133. [PubMed] [Google Scholar]
  11. Lieberthal W., Oza N. B., Bernard D. B., Levinsky N. G. The effect of cations on the activity of human urinary kallikrein. J Biol Chem. 1982 Sep 25;257(18):10827–10830. [PubMed] [Google Scholar]
  12. Maier M., Austen K. F., Spragg J. Kinetic analysis of the interaction of human tissue kallikrein with single-chain human high and low molecular weight kininogens. Proc Natl Acad Sci U S A. 1983 Jul;80(13):3928–3932. doi: 10.1073/pnas.80.13.3928. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Maier M., Starlinger M., Wagner M., Meyer D., Binder B. R. The effect of hemorrhagic hypotension on urinary kallikrein excretion, renin activity, and renal cortical blood flow in the pig. Circ Res. 1981 Mar;48(3):386–392. doi: 10.1161/01.res.48.3.386. [DOI] [PubMed] [Google Scholar]
  14. Maier M., Starlinger M., Zhegu Z., Rana H., Binder B. R. Effect of the protease inhibitor aprotinin on renal hemodynamics in the pig. Hypertension. 1985 Jan-Feb;7(1):32–38. doi: 10.1161/01.hyp.7.1.32. [DOI] [PubMed] [Google Scholar]
  15. Mason A. J., Evans B. A., Cox D. R., Shine J., Richards R. I. Structure of mouse kallikrein gene family suggests a role in specific processing of biologically active peptides. Nature. 1983 May 26;303(5915):300–307. doi: 10.1038/303300a0. [DOI] [PubMed] [Google Scholar]
  16. McGiff J. C., Terragno N. A., Malik K. U., Lonigro A. J. Release of a prostaglandin E-like substance from canine kidney by bradykinin. Circ Res. 1972 Jul;31(1):36–43. doi: 10.1161/01.res.31.1.36. [DOI] [PubMed] [Google Scholar]
  17. Mills I. H., Obika L. F., Newport P. A. Stimulation of the renal kallikrein-linin system by vasoactive substances and its relationship to the excretion of salt and water. Contrib Nephrol. 1978;12:132–144. doi: 10.1159/000401661. [DOI] [PubMed] [Google Scholar]
  18. Misumi J., Alhenc-Gelas F., Marre M., Marchetti J., Corvol P., Menard J. Regulation of kallikrein and renin release by the isolated perfused rat kidney. Kidney Int. 1983 Jul;24(1):58–65. doi: 10.1038/ki.1983.126. [DOI] [PubMed] [Google Scholar]
  19. Nustad K., Vaaje K., Pierce J. V. Synthesis of kallikreins by rat kidney slices. Br J Pharmacol. 1975 Feb;53(2):229–234. doi: 10.1111/j.1476-5381.1975.tb07353.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Robertson C. R., Deen W. M., Troy J. L., Brenner B. M. Dynamics of glomerular ultrafiltration in the rat. 3. Hemodynamics and autoregulation. Am J Physiol. 1972 Nov;223(5):1191–1200. doi: 10.1152/ajplegacy.1972.223.5.1191. [DOI] [PubMed] [Google Scholar]
  21. Roblero J., Croxatto H., García R., Corthorn J., De Vito E. Kallikreinlike activity in perfusates and urine of isolated rat kidneys. Am J Physiol. 1976 Nov;231(5 Pt 1):1383–1389. doi: 10.1152/ajplegacy.1976.231.5.1383. [DOI] [PubMed] [Google Scholar]
  22. Sealey J. E., Atlas S. A., Laragh J. H. Linking the kallikrein and renin systems via activation of inactive renin: new data and a hypothesis. Am J Med. 1978 Dec;65(6):994–1000. doi: 10.1016/0002-9343(78)90752-0. [DOI] [PubMed] [Google Scholar]
  23. WALTON R. P., RICHARDSON J. A., WALTON R. P., Jr, THOMPSON W. L. Sympathetic influences during hemorrhagic hypotension. Am J Physiol. 1959 Jul;197(1):223–230. doi: 10.1152/ajplegacy.1959.197.1.223. [DOI] [PubMed] [Google Scholar]
  24. Yang H. Y., Erdös E. G., Levin Y. Characterization of a dipeptide hydrolase (kininase II: angiotensin I converting enzyme). J Pharmacol Exp Ther. 1971 Apr;177(1):291–300. [PubMed] [Google Scholar]
  25. van Leeuwen B. H., Grinblat S. M., Johnston C. I. Tissue-specific control of glandular kallikreins. Am J Physiol. 1984 Nov;247(5 Pt 2):F760–F764. doi: 10.1152/ajprenal.1984.247.5.F760. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES